Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial

IMPORTANCE: The role of epidermal growth factor receptor (EGFR) inhibition in chemoradiation strategies in the nonoperative treatment of patients with esophageal cancer remains uncertain. OBJECTIVE: To evaluate the benefit of cetuximab added to concurrent chemoradiation therapy for patients undergoi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Oncol
Main Authors: Suntharalingam, Mohan, Winter, Kathryn, Ilson, David, Dicker, Adam P., Kachnic, Lisa, Konski, André, Chakravarthy, A. Bapsi, Anker, Christopher J., Thakrar, Harish, Horiba, Naomi, Dubey, Ajay, Greenberger, Joel S., Raben, Adam, Giguere, Jeffrey, Roof, Kevin, Videtic, Gregory, Pollock, Jondavid, Safran, Howard, Crane, Christopher H.
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2017
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710193/
https://ncbi.nlm.nih.gov/pubmed/28687830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.1598
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker